Allergan Inc. (AGN) Stock Quote

Detailed Quote for Allergan Inc. (AGN)

After Hours: $ 87.05

0.00 (0.00%)

Volume: 43.24 k

4:58 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

January 26, 2012

Close: 90.00

52 Week Low

March 23, 2011

Close: 68.03

Today

Last Price
87.05

Change $
0.33

Change %
0.38%

Tick
N/A

Bid
85.76

Bid Size
100

Ask
N/A

Ask Size
0

Open
86.96

High
87.34

Low
86.56

Prev Close
87.38

Last Trade
4:01

Volume
1.39 m

52 Wk Hi
90.00

52 Wk Low
68.03

Market Cap
26.55 b

Ex-Div Date
2/22/12

Div Rate
0.20

Yield
0.229753

Shares
305,032,041

EPS (TTM)
3.01

PE Ratio
29.00

close Exchange Information Listed On New York Stock Exchange (NYE) Exchange
NYE

News and Media for Allergan Inc. (AGN)

Sector News | Topic News

News for AGN

Thu, Feb 02, 2012

9:00 AM

Allergan Reports Fourth Quarter 2011 Operating Results - Business Wire

Fri, Jan 06, 2012

6:30 PM

Allergan Announces Quarterly Conference Call - Business Wire

Wed, Nov 09, 2011

8:00 AM

Actress Christina Hendricks Urges Women to Join Her in the Final Weeks of the LATISSE® Wishes Challenge to Increase Money Raised for the Make-A-Wish Foundation® from $390,000 to Campaign Goal of $500,000 - PR Newswire

Tue, Oct 18, 2011

9:10 AM

Analyst View, Impact of Global Events - Research Report on ADTRAN, Inc. and Allergan, Inc. - Marketwire

Thu, Oct 06, 2011

9:00 AM

Award-winning Actress Courtney Thorne-Smith and Allergan, Inc. Reveal Changes in Women's Perceptions of BOTOX Cosmetic Over Nearly a Decade - PR Newswire

Fri, Sep 23, 2011

9:30 AM

Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals - PR Newswire

9:00 AM

Global Situation & Resulting Influences - Research Report on Oculus Innovative Sciences, Inc. and Allergan, Inc. - Marketwire

Wed, Sep 21, 2011

8:00 AM

National Headache Foundation, HealthyWomen and Allergan Offer People Living With Chronic Migraine a Chance to "Rewrite Your Day" - PR Newswire

Mon, Jun 27, 2011

9:14 AM

Equity Research on Allergan, Inc. and ISTA Pharmaceuticals, Inc.- Prescribing the Advantage in Bio Pharmaceuticals - Marketwire

Thu, Feb 17, 2011

11:22 PM

Lap-Band approved for those less obese - UPI

Thu, Nov 25, 2010

12:24 PM

New treatment targets natural tears for dry eyes - Canada Newswire

8:00 AM

NEW TREATMENT TARGETS NATURAL TEARS FOR DRY EYES - Canada Newswire

Wed, Mar 03, 2010

6:55 AM

Allergan Celebrates 20 Years of Approved Use of Botulinum Toxin Type A (BOTOX(R)) in Canada - Canada Newswire

6:55 AM

Allergan célèbre les 20 ans de l'approbation de la toxine botulinique de type A (BOTOX(R)) au Canada - Canada Newswire

Fri, Sep 11, 2009

3:48 PM

Clemex divulgue les résultats de son premier trimestre pour 2010 - Canada Newswire

3:45 PM

Clemex Discloses First Quarter Results for FY 2010 - Canada Newswire

Mon, Oct 24, 2005

9:01 AM

NPS Pharmaceuticals to Promote Allergan's RESTASIS(R) to Rheumatologists in the United States - Canada Newswire

More News for AGN >>

Tags for Allergan Inc.

Research stocks or mutual funds related to Allergan Inc. by keywords or tags. Find companies that have a similar focus to AGN. The keywords below have been associated to AGN by either user submission or electronic means.

collagen treatment eye infection allergan company acne facial treatment dry eyes wrinkle reduction acne skin treatments allergan india dermal filler training eye associates facial treatments laser hair removal skin acne problem myopia treatment allergan australia eye disorders skin care cosmetics dermal fillers allergan access treatment for acne glaucoma www allergan com cataract eye surgery eye doctors facial skin care products facial skin care Drugs allergan relief facial beauty dry eye symptoms skin care laser www allergan lasik dry eyes anti aging treatments eye diseases family eye care eye specialists laser eye surgery cataract acne skin care products beauty treatments allergan canada microdermabrasion treatment Healthcare allergan eye drops watery eye wrinkle reducers eye physicians allergan eye care cataract treatment